Grufity logo
Grufity logo
VNRX

VNRX - VolitionRX Ltd Stock Price, Fair Value and News

$1.40-0.04 (-2.78%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

44/100

VNRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

44/100

VNRX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

VNRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VNRX Price Action

Last 7 days

2.9%

Last 30 days

-28.5%

Last 90 days

-62.4%

Trailing 12 Months

-88.8%

VNRX RSI Chart

VNRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VNRX Valuation

Market Cap

11.4M

Price/Earnings (Trailing)

-0.46

Price/Sales (Trailing)

4.63

Price/Free Cashflow

-0.55

VNRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

VNRX Fundamentals

VNRX Revenue

Revenue (TTM)

2.5M

Rev. Growth (Yr)

299.81%

Rev. Growth (Qtr)

120.36%

VNRX Earnings

Earnings (TTM)

-24.6M

Earnings Growth (Yr)

-21.69%

Earnings Growth (Qtr)

-6.99%

VNRX Profitability

Return on Equity

73.7%

Return on Assets

-272.08%

Free Cashflow Yield

-181.81%

VNRX Investor Care

Shares Dilution (1Y)

57.44%

Diluted EPS (TTM)

-4.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20262.5M---
20251.3M1.3M1.5M1.7M
2024797.0K976.5K1.3M1.2M
2023342.0K518.5K651.0K775.3K
2022178.7K193.7K200.9K306.4K
202138.4K58.0K82.9K90.0K
2020-49.9K22.9K12.9K
2019--72.1K56.4K
2012----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About VolitionRX Ltd

VNRX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.
 CEO
 WEBSITEhttps://volition.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES111

VolitionRX Ltd Frequently Asked Questions

VNRX is the stock ticker symbol of VolitionRX Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of VolitionRX Ltd is 11.42 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, VNRX's PE ratio (Price to Earnings) is -0.46 and Price to Sales (PS) ratio is 4.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VNRX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, VolitionRX Ltd has provided -0.319 (multiply by 100 for percentage) rate of return.